{"orpha":251529,"name":"Toxic or drug-related embryofetopathy","type":"Category","group":"Group of disorders","status":"active","flags":[],"synonyms":[],"definition":null,"note":"This term does not characterize a disease but a group of diseases. To learn about the diseases included under this term, you can consult the classifications.","url":"https://raremap.alftech.space/d/ORPHA-251529/","orphanet_url":"https://www.orpha.net/en/disease/detail/251529","names":{"fr":{"name":"Embryofoetopathie d'exposition toxique ou médicamenteuse"},"de":{"name":"Embryopathie, toxische oder Medikamenten-induzierte"},"es":{"name":"Embriofetopatía tóxica o asociada a fármacos","synonyms":["Embriofetopatía tóxica o asociada a medicamentos"]},"it":{"name":"Embriofetopatia da esposizione tossica o farmacologica"},"nl":{"name":"Toxische of medicatiegerelateerde embryofoetopathie"},"pt":{"name":"Embriofetopatia tóxica ou relacionada com fármacos"},"pl":{"name":"Embriofetopatia związana z zatruciem lub lekiem"},"cs":{"name":"Embryofetopatie vázaná s drogami nebo léky"},"uk":{"name":"Токсична або медикаментозна ембріофетопатія"},"zh":{"name":"毒物或药物相关胚胎胎儿病"},"tr":{"name":"Toksik veya ilaç-ilişkili embriyofetopati"}},"xrefs":[{"source":"ICD-11","code":"LD2F.0","qualifier":"E","icd_relation":"specific","validated":true,"icd11_uri":"293076727"},{"source":"MONDO","code":"0016677","qualifier":"E","icd_relation":null,"validated":true},{"source":"MONDO","code":"16677","qualifier":"E","icd_relation":null,"validated":true},{"source":"UMLS","code":"C5680710","qualifier":"E","icd_relation":null,"validated":true}],"associations":[],"incoming_associations":[],"preferential_parent":{"orpha":93890,"name":"Rare developmental defect during embryogenesis"},"parents":[{"orpha":108999,"name":"Rare disorder due to toxic effects","classifications":[204]},{"orpha":52662,"name":"Rare teratologic disease","classifications":[147,216]}],"children":[{"orpha":40366,"name":"Acitretin/etretinate embryopathy","type":"Malformation syndrome"},{"orpha":1908,"name":"Aminopterin/methotrexate embryofetopathy","type":"Malformation syndrome"},{"orpha":1911,"name":"Cocaine embryofetopathy","type":"Malformation syndrome"},{"orpha":1916,"name":"Diethylstilbestrol syndrome","type":"Malformation syndrome"},{"orpha":1915,"name":"Fetal alcohol syndrome","type":"Malformation syndrome"},{"orpha":370068,"name":"Fetal anticonvulsant syndrome","type":"Clinical group"},{"orpha":1910,"name":"Fetal iodine syndrome","type":"Malformation syndrome"},{"orpha":1917,"name":"Fetal methylmercury syndrome","type":"Malformation syndrome"},{"orpha":1918,"name":"Fetal minoxidil syndrome","type":"Malformation syndrome"},{"orpha":1909,"name":"Indomethacin embryofetopathy","type":"Malformation syndrome"},{"orpha":2305,"name":"Isotretinoin syndrome","type":"Malformation syndrome"},{"orpha":1923,"name":"Methimazole embryofetopathy","type":"Malformation syndrome"},{"orpha":268249,"name":"Mycophenolate mofetil embryopathy","type":"Malformation syndrome"},{"orpha":485358,"name":"Propylthiouracil embryofetopathy","type":"Malformation syndrome"},{"orpha":3312,"name":"Thalidomide embryopathy","type":"Malformation syndrome"},{"orpha":1920,"name":"Toluene embryopathy","type":"Malformation syndrome"},{"orpha":1914,"name":"Vitamin K antagonist embryofetopathy","type":"Malformation syndrome"}],"genes":[],"genes_via_subtypes":[],"inheritance":[],"onset":[],"prevalence":[],"phenotypes":null}